CLINICAL_TRIALS
trial_result
· 2017-09-21
Clinical Trial Update: Safety and Efficacy Trial of Testosterone Undecanoate [Phase 3]
Summary
Phase 3 safety and efficacy trial of testosterone undecanoate for male hypogonadism has completed, with results posted in September 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Clarus Therapeutics, Inc. | Conditions: Male Hypogonadism | Phase 3 | Status: COMPLETED | Results posted: 2017-09-21